The basis for breakthroughs
Aldevron products are used in multiple research applications around the world. We've gathered some of the articles and papers developed from projects using Aldevron products. This is not a complete list; some may require subscriptions or payment to access a full copy, while others are freely available dependent on licensing.
Disclaimer: Links provided below are to non-Aldevron websites. Aldevron is not responsible for the content of these sites, nor do we have any role in the operation of these sites.
2021
Published | Citation |
3 August 2021 | Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication
|
2 August 2021 | Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells |
1 August 2021 | KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1
|
16 July 2021 | A stress-free strategy to correct point mutations in patient iPS cells
|
5 March 2021 | Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome
|
28 January 2021 |
Targeted Gene Editing in Porcine Spermatogonia
|
Disclaimer: Links provided are to non-Aldevron websites. Aldevron is not responsible for the content of these sites, nor do we have any role in the operation of these sites.
2020
Published | Citation |
8 December 2020 |
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases
|
4 December 2020 |
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
|
27 October 2020 |
CRISPRoff enables spatio-temporal control of CRISPR editing
|
3 October 2020 |
A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures
|
24 September 2020 |
Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses
|
10 August 2020 |
|
28 July 2020 |
|
27 July 2020 |
|
30 June 2020 |
Discovering How Heme Controls Genome Function Through Heme-omics
|
29 June 2020 |
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
|
10 April 2020 | Nucleobindin-2 enhances the epithelial-mesenchymal transition in renal cell carcinoma |
10 February 2020 | Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
|
Disclaimer: Links provided are to non-Aldevron websites. Aldevron is not responsible for the content of these sites, nor do we have any role in the operation of these sites.
2019
Published | Citation |
9 December 2019 |
|
27 November 2019 | Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations
|
19 November 2019 | Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors |
14 October 2019 | A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
|
19 August 2019 |
|
21 June 2019 | Identification of Guide-Intrinsic Determinants of Cas9 Specificity
|
4 April 2019 | Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
|
Disclaimer: Links provided are to non-Aldevron websites. Aldevron is not responsible for the content of these sites, nor do we have any role in the operation of these sites.
2018
Published | Citation |
31 October 2018 | Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo
|
17 September 2018 | Versatile Redox-Responsive Polyplexes for the Delivery of Plasmid DNA, Messenger RNA, and CRISPR-Cas9 Genome-Editing Machinery
|
15 June 2018 | Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
|
6 June 2018 | A Universal GSH-Responsive Nanoplatform for the Delivery of DNA, mRNA, and Cas9/sgRNA Ribonucleoprotein
|
22 March 2018 | CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression
|
15 February 2018 | Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
|
2 February 2018 | Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector
|
16 January 2018 | A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers
|
9 January 2018 | A novel one-step approach for the construction of yeast surface display Fab antibody libraries
|
3 January 2018 | Synthesis and characterization of bioreducible cationic biarm polymer for efficient gene delivery
|
Disclaimer: Links provided are to non-Aldevron websites. Aldevron is not responsible for the content of these sites, nor do we have any role in the operation of these sites.
2017
Published | Citation |
26 December 2017 |
|
6 December 2017 |
|
28 November 2017 |
|
23 November 2017 |
|
22 November 2017 |
|
22 November 2017 |
|
21 November 2017 |
|
11 November 2017 |
Comprehensive Molecular Characterization of a Cisplatin-Specific Monoclonal Antibody
|
20 September 2017 |
|
11 September 2017 |
CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide
|
8 July 2017 | The power of bioluminescence imaging in understanding host-pathogen interactions
|
1 July 2017 |
|
24 June 2017 |
Sickle Cells Produce Functional Immune Modulators and Cytotoxics
|
1 June 2017 | Hepatitis B Virus Vaccine–Induced Cell-Mediated Immunity Correlates with Humoral Immune Response following Primary Vaccination during Infancy
|
22 May 2017 |
|
15 May 2017 | Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus
|
5 May 2017 |
|
April 2017 |
|
14 April 2017 |
|
13 April 2017 |
Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease
|
12 April 2017 |
An HIV envelope gp120-Fc fusion protein elicits effector antibody responses in rhesus macaques
|
6 April 2017 |
|
30 March 2017 |
|
27 March 2017 |
Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma
|
6 January 2017 | Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display
|
Disclaimer: Links provided are to non-Aldevron websites. Aldevron is not responsible for the content of these sites, nor do we have any role in the operation of these sites. |